PPARγ and Its Role in Cardiovascular Diseases
Mini Chandra1, Sumitra Miriyala1, Manikandan Panchatcharam1
1Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, USA.
Abstract:
Peroxisome proliferator-activated receptor Gamma (PPARγ), a ligand-activated transcription factor, has a role in various cellular functions as well as glucose homeostasis, lipid metabolism, and prevention of oxidative stress. The activators of PPARγ are already widely used in the treatment of diabetes mellitus. The cardioprotective effect of PPARγ activation has been studied extensively over the years making them potential therapeutic targets in diseases associated with cardiovascular disorders. However, they are also associated with adverse cardiovascular events such as congestive heart failure and myocardial infarction. This review aims to discuss the role of PPARγ in the various cardiovascular diseases and summarize the current knowledge on PPARγ agonists from multiple clinical trials. Finally, we also review the new PPARγ agonists under development as potential therapeutics with reduced or no adverse effects.
Related Concept Videos
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
GPCRs Regulate Adenylyl Cylase Activity
Cholesterol: Significance and Regulation
Considering cholesterol and...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction


